During a 25-month period ending in June 2012 , 209 eligible patients scheduled to undergo elective prosthetic femoral to above-knee or below-knee popliteal bypass were randomized to receive a standard expanded polytetrafluoroethylene ( ePTFE ) graft or the heparin-coated FUSION BIOLINE vascular graft .